Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Porda Havas International Financial Communications Group
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China
2020-10-22 10:36
Sihuan Pharmaceutical Invests in Phase I Fund of Ascendum Capital Life Technology to Expand its Strategy in Development of Innovative Drugs
2020-10-20 11:09
JHBP (CY) Holdings Limited (6998.HK) Successfully listed on the Main Board of SEHK
2020-10-07 18:05
Announcement of Memorandum of Understanding for a Business Alliance of 5G/AI Related Businesses
2020-10-05 14:30
Genor Biopharma Announces Proposed Listing on the Main Board of SEHK
2020-09-23 12:00
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
2020-09-21 09:25
Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program
2020-09-17 20:25
Sihuan Pharmaceutical (0460.HK): Under innovation transformation, an internationalized new pattern in construction
2020-09-15 18:05
Venus Medtech Taps into Surgical Heart Valve Market by Cooperating with Haoyue Group to Develop the Business of High-end Biomaterial Medical Devices
2020-09-10 17:56
Ping An of China Asset Management (Hong Kong) Awarded "Asset Management Firm of the Year" at Asia Risk Awards 2020
2020-09-08 19:00
Viva Biotech Announced 2020 Interim Results
2020-08-31 23:27
SDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&D
2020-08-24 10:20
Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry
2020-08-20 19:39
Ping An of China Asset Management (Hong Kong) Launches First Co-branded Fund with Hang Seng Investment Management
2020-08-18 16:00
Lee's Pharm Announced 2020 Interim Results Positive Profit Alert
2020-08-14 23:49
Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry
2020-08-10 08:00
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
2020-07-29 07:00
New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia
2020-07-28 17:59
Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China
2020-07-14 18:19
Viva BioInnovator (VBI) Successfully Held 1st Demo Day
2020-06-17 16:40
1
3
4
5
6
7
17